Table 1.
Baseline characteristics of vaccine-naïve participants enrolled by type of vaccines.
| Baseline characteristics | Type of vaccinations following SARS-CoV-2 detection |
||||
| Total | BNT162b2 | ChAdOx1 | CoronaVac | P value | |
| Number of participants, n (%) | 114 | 31 (27.2) | 45 (39.5) | 38 (33.3) | |
| Male, n (%) | 52 | 14 (45.2) | 19 (42.2) | 19 (50.0) | 0.78 |
| Age, median (IQR) | 38.5 (29, 45) | 37 (28, 44) | 39 (29, 48) | 39 (29, 45) | 0.90 |
| Body mass index, median (IQR) | 24.40 (21.0, 27.4) | 23.3 (20.3, 26.4) | 24.5 (21.8, 27.4) | 25.4 (21.1, 28.6) | 0.17 |
| Days from diagnosis to enrollment, median (IQR) |
85 (61, 119) | 67 (54, 126) | 111(61, 120) | 88 (62, 114) | 0.20 |